Suprathreshold repetitive transcranial magnetic stimulation elevates thyroid-stimulating hormone in healthy male subjects.
Repetitive transcranial magnetic stimulation (rTMS) has been introduced as a new antidepressive treatment strategy. The mode of action by which the antidepressive effect is brought about is not yet clear. Other antidepressive treatment strategies such as sleep deprivation are associated with an increase of plasma thyroid-stimulating hormone (TSH) levels that correlate with clinical improvement. In the present study, the effect of left prefrontal suprathreshold (120% of motor threshold) rTMS on TSH plasma levels of 19 healthy male subjects was investigated in comparison with subthreshold (80% of motor threshold) and sham stimulation. Suprathreshold rTMS was followed by a significant relative increase of TSH levels 10 and 60 minutes after stimulation in comparison with subthreshold and sham stimulation. The more pronounced effect of suprathreshold rTMS on TSH plasma levels might be important for the determination of optimal stimulation parameters in the treatment of depressed patients.
Cohrs
S
S
Department of Psychiatry and Psychotherapy, Georg-August University, Göttingen, Germany.
Tergau
F
F
Korn
J
J
Becker
W
W
Hajak
G
G
D000328:Adult; D002940:Circadian Rhythm / Q000502:physiology; D003866:Depressive Disorder / Q000097:blood / Q000628:therapy; D007839:Functional Laterality / Q000502:physiology; D006801:Humans; D008297:Male; D009044:Motor Cortex / Q000502:physiology; D017397:Prefrontal Cortex / Q000502:physiology*; D013961:Thyroid Gland / Q000502:physiology; D013972:Thyrotropin / Q000097:blood*; D050781:Transcranial Magnetic Stimulation / Q000627:therapeutic use
D013972:Thyrotropin